These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8190022)

  • 61. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Replacement of the conserved tyrosine 1210 by phenylalanine in the insulin receptor affects insulin-induced dephosphorylation of focal adhesion kinase but leaves other responses intact.
    Van der Zon GC; Ouwens DM; Dorrestijn J; Maassen JA
    Biochemistry; 1996 Aug; 35(32):10377-82. PubMed ID: 8756693
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats.
    Hurrell DG; Pedersen O; Kahn CR
    Endocrinology; 1989 Nov; 125(5):2454-62. PubMed ID: 2551653
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Angiotensin II modulates tyr-phosphorylation of IRS-4, an insulin receptor substrate, in rat liver membranes.
    Villarreal RS; Alvarez SE; Ayub MJ; Ciuffo GM
    Mol Cell Biochem; 2006 Dec; 293(1-2):35-46. PubMed ID: 16933034
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Insulin receptor tyrosine kinase activity is reduced in monocytes from non-obese normoglycaemic insulin-resistant subjects.
    Frittitta L; Grasso G; Munguira ME; Vigneri R; Trischitta V
    Diabetologia; 1993 Nov; 36(11):1163-7. PubMed ID: 8270131
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of cardiac insulin receptor function by guanosine nucleotides.
    Russ M; Reinauer H; Eckel J
    FEBS Lett; 1993 Feb; 317(1-2):72-6. PubMed ID: 8428637
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The level of insulin receptor tyrosine kinase activity modulates the activities of phosphatidylinositol 3-kinase, microtubule-associated protein, and S6 kinases.
    Wilden PA; Kahn CR
    Mol Endocrinol; 1994 May; 8(5):558-67. PubMed ID: 8058065
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.
    Rowlinson SW; Waters MJ; Lewis UJ; Barnard R
    Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.
    Jiang ZY; Lin YW; Clemont A; Feener EP; Hein KD; Igarashi M; Yamauchi T; White MF; King GL
    J Clin Invest; 1999 Aug; 104(4):447-57. PubMed ID: 10449437
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC; Carvalho CR; Saad MJ
    Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Conformational analysis of human growth hormone [6-13] peptide analogues.
    Higgins KA; Thompson PE; Hearn MT
    Int J Pept Protein Res; 1996 Jul; 48(1):1-11. PubMed ID: 8844258
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of modified insulin B21-B26 fragments on glycogenesis and on insulin-receptor complex fate in cultured fetal hepatocytes.
    Menuelle P; Plas C; Taketomi S
    Mol Cell Endocrinol; 1989 Oct; 66(2):143-51. PubMed ID: 2693157
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human urinary insulin-potentiating peptide: immunological evidence for the absence of the human growth hormone amino terminal sequence, Phe-Pro-Thr-Ile-Pro-.
    Stephenson FA; Bornstein J
    Mol Cell Endocrinol; 1981 Aug; 23(2):187-92. PubMed ID: 7274549
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular and cellular actions of a structural domain of human growth hormone (AOD9401) on lipid metabolism in Zucker fatty rats.
    Ng FM; Jiang WJ; Gianello R; Pitt S; Roupas P
    J Mol Endocrinol; 2000 Dec; 25(3):287-98. PubMed ID: 11116208
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative phosphorylation kinetics of the human insulin receptor protein-tyrosine kinase domain and an enzymatically competent deletion construct--the tail could wag the dog.
    Quirk PG; Keane NE; Levine BA; Wei L; Ellis L
    Biochem Soc Trans; 1995 May; 23(2):188S. PubMed ID: 7672210
    [No Abstract]   [Full Text] [Related]  

  • 76. Modulation of rat brain insulin receptor kinase activity in diabetes.
    Gupta G; Azam M; Baquer NZ
    Neurochem Int; 1992 Jun; 20(4):487-92. PubMed ID: 1339020
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diabetogenic action of human growth hormone. Synthesis and activity of C-terminal fragments.
    Wade JD; Ng FM; Bornstein J
    Int J Pept Protein Res; 1979 Feb; 13(2):195-200. PubMed ID: 429095
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular heterogeneity of human GH: from basic research to clinical implications.
    Boguszewski CL
    J Endocrinol Invest; 2003 Mar; 26(3):274-88. PubMed ID: 12809181
    [No Abstract]   [Full Text] [Related]  

  • 79. Stimulation of insulin receptor tyrosine kinase activity by an amino terminal sequence of human growth hormone.
    Lim N; Wijaya E; Ng F
    Life Sci; 1994; 54(20):1471-81. PubMed ID: 8190022
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modulation of hepatic insulin receptors by a human growth hormone fragment (hGH 6-13).
    Ng F; Henderson T; Bromley J; Bornstein J
    Mol Cell Endocrinol; 1983 Apr; 30(1):63-71. PubMed ID: 6341118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.